nodes	percent_of_prediction	percent_of_DWPC	metapath
Prednicarbate—Allergic contact dermatitis—Estradiol—osteoporosis	0.0532	0.062	CcSEcCtD
Prednicarbate—Eruption—Estradiol—osteoporosis	0.0302	0.0352	CcSEcCtD
Prednicarbate—Testolactone—CYP19A1—osteoporosis	0.0224	0.331	CrCbGaD
Prednicarbate—Oedema—Calcium Acetate—osteoporosis	0.0221	0.0258	CcSEcCtD
Prednicarbate—Paraesthesia—Calcium Acetate—osteoporosis	0.0198	0.0231	CcSEcCtD
Prednicarbate—Pain—Calcium Acetate—osteoporosis	0.0189	0.022	CcSEcCtD
Prednicarbate—Dermatitis contact—Estradiol—osteoporosis	0.0184	0.0214	CcSEcCtD
Prednicarbate—Pain—Ergocalciferol—osteoporosis	0.0167	0.0195	CcSEcCtD
Prednicarbate—Pruritus—Calcium Acetate—osteoporosis	0.0156	0.0182	CcSEcCtD
Prednicarbate—Infection—Etidronic acid—osteoporosis	0.0144	0.0168	CcSEcCtD
Prednicarbate—Medroxyprogesterone Acetate—SHBG—osteoporosis	0.0132	0.195	CrCbGaD
Prednicarbate—Paraesthesia—Etidronic acid—osteoporosis	0.013	0.0152	CcSEcCtD
Prednicarbate—Oedema—Estropipate—osteoporosis	0.0125	0.0146	CcSEcCtD
Prednicarbate—Infection—Estropipate—osteoporosis	0.0125	0.0145	CcSEcCtD
Prednicarbate—Infection—Alendronate—osteoporosis	0.0123	0.0143	CcSEcCtD
Prednicarbate—Infection—Raloxifene—osteoporosis	0.0121	0.0141	CcSEcCtD
Prednicarbate—Infection—Ibandronate—osteoporosis	0.0119	0.0139	CcSEcCtD
Prednicarbate—Urticaria—Etidronic acid—osteoporosis	0.0115	0.0134	CcSEcCtD
Prednicarbate—Paraesthesia—Estropipate—osteoporosis	0.0113	0.0131	CcSEcCtD
Prednicarbate—Paraesthesia—Ibandronate—osteoporosis	0.0108	0.0126	CcSEcCtD
Prednicarbate—Pain—Estropipate—osteoporosis	0.0107	0.0125	CcSEcCtD
Prednicarbate—Pain—Alendronate—osteoporosis	0.0106	0.0123	CcSEcCtD
Prednicarbate—Pain—Raloxifene—osteoporosis	0.0104	0.0121	CcSEcCtD
Prednicarbate—Pain—Ibandronate—osteoporosis	0.0103	0.012	CcSEcCtD
Prednicarbate—Pruritus—Etidronic acid—osteoporosis	0.0103	0.012	CcSEcCtD
Prednicarbate—Oedema—Ethinyl Estradiol—osteoporosis	0.0102	0.0119	CcSEcCtD
Prednicarbate—Infection—Ethinyl Estradiol—osteoporosis	0.0101	0.0118	CcSEcCtD
Prednicarbate—Pain—Calcitriol—osteoporosis	0.0101	0.0117	CcSEcCtD
Prednicarbate—Urticaria—Estropipate—osteoporosis	0.00996	0.0116	CcSEcCtD
Prednicarbate—Infection—Risedronate—osteoporosis	0.00985	0.0115	CcSEcCtD
Prednicarbate—Urticaria—Alendronate—osteoporosis	0.00981	0.0114	CcSEcCtD
Prednicarbate—Urticaria—Ibandronate—osteoporosis	0.00956	0.0111	CcSEcCtD
Prednicarbate—Oedema—Pamidronate—osteoporosis	0.00942	0.011	CcSEcCtD
Prednicarbate—Hydrocortisone—SHBG—osteoporosis	0.00937	0.138	CrCbGaD
Prednicarbate—Infection—Pamidronate—osteoporosis	0.00936	0.0109	CcSEcCtD
Prednicarbate—Urticaria—Calcitriol—osteoporosis	0.00935	0.0109	CcSEcCtD
Prednicarbate—Rash—Etidronic acid—osteoporosis	0.00914	0.0107	CcSEcCtD
Prednicarbate—Dermatitis—Etidronic acid—osteoporosis	0.00913	0.0106	CcSEcCtD
Prednicarbate—Medroxyprogesterone Acetate—ESR1—osteoporosis	0.00892	0.132	CrCbGaD
Prednicarbate—Paraesthesia—Risedronate—osteoporosis	0.0089	0.0104	CcSEcCtD
Prednicarbate—Pruritus—Estropipate—osteoporosis	0.00887	0.0103	CcSEcCtD
Prednicarbate—Betamethasone—CYP19A1—osteoporosis	0.00881	0.13	CrCbGaD
Prednicarbate—Pruritus—Alendronate—osteoporosis	0.00874	0.0102	CcSEcCtD
Prednicarbate—Oedema—Zoledronate—osteoporosis	0.00861	0.01	CcSEcCtD
Prednicarbate—Infection—Zoledronate—osteoporosis	0.00855	0.00997	CcSEcCtD
Prednicarbate—Pruritus—Ibandronate—osteoporosis	0.00851	0.00992	CcSEcCtD
Prednicarbate—Pain—Risedronate—osteoporosis	0.00848	0.00988	CcSEcCtD
Prednicarbate—Paraesthesia—Pamidronate—osteoporosis	0.00846	0.00987	CcSEcCtD
Prednicarbate—Pruritus—Calcitriol—osteoporosis	0.00833	0.00971	CcSEcCtD
Prednicarbate—Oedema—Conjugated Estrogens—osteoporosis	0.00829	0.00966	CcSEcCtD
Prednicarbate—Infection—Conjugated Estrogens—osteoporosis	0.00823	0.0096	CcSEcCtD
Prednicarbate—Urticaria—Ethinyl Estradiol—osteoporosis	0.00808	0.00942	CcSEcCtD
Prednicarbate—Pain—Pamidronate—osteoporosis	0.00806	0.0094	CcSEcCtD
Prednicarbate—Rash—Estropipate—osteoporosis	0.00791	0.00922	CcSEcCtD
Prednicarbate—Dermatitis—Estropipate—osteoporosis	0.0079	0.00921	CcSEcCtD
Prednicarbate—Urticaria—Risedronate—osteoporosis	0.00788	0.00918	CcSEcCtD
Prednicarbate—Rash—Alendronate—osteoporosis	0.00779	0.00908	CcSEcCtD
Prednicarbate—Dermatitis—Alendronate—osteoporosis	0.00778	0.00907	CcSEcCtD
Prednicarbate—Paraesthesia—Zoledronate—osteoporosis	0.00773	0.00901	CcSEcCtD
Prednicarbate—Rash—Raloxifene—osteoporosis	0.00766	0.00893	CcSEcCtD
Prednicarbate—Dermatitis—Raloxifene—osteoporosis	0.00765	0.00892	CcSEcCtD
Prednicarbate—Rash—Ibandronate—osteoporosis	0.00758	0.00884	CcSEcCtD
Prednicarbate—Dermatitis—Ibandronate—osteoporosis	0.00758	0.00884	CcSEcCtD
Prednicarbate—Paraesthesia—Conjugated Estrogens—osteoporosis	0.00744	0.00868	CcSEcCtD
Prednicarbate—Rash—Calcitriol—osteoporosis	0.00742	0.00866	CcSEcCtD
Prednicarbate—Dermatitis—Calcitriol—osteoporosis	0.00742	0.00865	CcSEcCtD
Prednicarbate—Pain—Zoledronate—osteoporosis	0.00736	0.00858	CcSEcCtD
Prednicarbate—Pruritus—Ethinyl Estradiol—osteoporosis	0.00719	0.00839	CcSEcCtD
Prednicarbate—Pain—Conjugated Estrogens—osteoporosis	0.00709	0.00826	CcSEcCtD
Prednicarbate—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—RAP1A—osteoporosis	0.00705	0.0947	CbGpPWpGaD
Prednicarbate—Pruritus—Risedronate—osteoporosis	0.00701	0.00818	CcSEcCtD
Prednicarbate—NR3C1—Signaling events mediated by HDAC Class II—TUBA1B—osteoporosis	0.007	0.0939	CbGpPWpGaD
Prednicarbate—Urticaria—Zoledronate—osteoporosis	0.00684	0.00797	CcSEcCtD
Prednicarbate—Pruritus—Pamidronate—osteoporosis	0.00667	0.00777	CcSEcCtD
Prednicarbate—Oedema—Estradiol—osteoporosis	0.00663	0.00773	CcSEcCtD
Prednicarbate—Infection—Estradiol—osteoporosis	0.00659	0.00768	CcSEcCtD
Prednicarbate—Urticaria—Conjugated Estrogens—osteoporosis	0.00658	0.00768	CcSEcCtD
Prednicarbate—Rash—Ethinyl Estradiol—osteoporosis	0.00641	0.00747	CcSEcCtD
Prednicarbate—Dermatitis—Ethinyl Estradiol—osteoporosis	0.0064	0.00747	CcSEcCtD
Prednicarbate—Rash—Risedronate—osteoporosis	0.00625	0.00729	CcSEcCtD
Prednicarbate—Dermatitis—Risedronate—osteoporosis	0.00624	0.00728	CcSEcCtD
Prednicarbate—Pruritus—Zoledronate—osteoporosis	0.00609	0.0071	CcSEcCtD
Prednicarbate—Paraesthesia—Estradiol—osteoporosis	0.00596	0.00695	CcSEcCtD
Prednicarbate—Rash—Pamidronate—osteoporosis	0.00594	0.00693	CcSEcCtD
Prednicarbate—Dermatitis—Pamidronate—osteoporosis	0.00594	0.00692	CcSEcCtD
Prednicarbate—Pruritus—Conjugated Estrogens—osteoporosis	0.00586	0.00684	CcSEcCtD
Prednicarbate—Pain—Estradiol—osteoporosis	0.00567	0.00661	CcSEcCtD
Prednicarbate—Rash—Zoledronate—osteoporosis	0.00543	0.00633	CcSEcCtD
Prednicarbate—Dermatitis—Zoledronate—osteoporosis	0.00542	0.00632	CcSEcCtD
Prednicarbate—Urticaria—Estradiol—osteoporosis	0.00527	0.00614	CcSEcCtD
Prednicarbate—Rash—Conjugated Estrogens—osteoporosis	0.00523	0.00609	CcSEcCtD
Prednicarbate—Dermatitis—Conjugated Estrogens—osteoporosis	0.00522	0.00609	CcSEcCtD
Prednicarbate—Dexamethasone—CYP19A1—osteoporosis	0.00512	0.0755	CrCbGaD
Prednicarbate—Pruritus—Estradiol—osteoporosis	0.00469	0.00547	CcSEcCtD
Prednicarbate—Rash—Estradiol—osteoporosis	0.00418	0.00488	CcSEcCtD
Prednicarbate—Dermatitis—Estradiol—osteoporosis	0.00418	0.00487	CcSEcCtD
Prednicarbate—NR3C1—Transcription factor regulation in adipogenesis—IRS2—osteoporosis	0.0029	0.0389	CbGpPWpGaD
Prednicarbate—NR3C1—Nuclear Receptors—ESR2—osteoporosis	0.00288	0.0387	CbGpPWpGaD
Prednicarbate—NR3C1—Transcription factor regulation in adipogenesis—LEP—osteoporosis	0.00284	0.0381	CbGpPWpGaD
Prednicarbate—NR3C1—AP-1 transcription factor network—COL1A2—osteoporosis	0.00255	0.0342	CbGpPWpGaD
Prednicarbate—NR3C1—Transcription factor regulation in adipogenesis—IRS1—osteoporosis	0.00253	0.034	CbGpPWpGaD
Prednicarbate—NR3C1—Endoderm Differentiation—DKK1—osteoporosis	0.00246	0.033	CbGpPWpGaD
Prednicarbate—NR3C1—AP-1 transcription factor network—NFATC1—osteoporosis	0.00242	0.0325	CbGpPWpGaD
Prednicarbate—NR3C1—Nuclear Receptors—VDR—osteoporosis	0.00229	0.0307	CbGpPWpGaD
Prednicarbate—NR3C1—Nuclear Receptor transcription pathway—ESR2—osteoporosis	0.00228	0.0306	CbGpPWpGaD
Prednicarbate—NR3C1—Regulation of nuclear SMAD2/3 signaling—COL1A2—osteoporosis	0.00227	0.0305	CbGpPWpGaD
Prednicarbate—NR3C1—Endoderm Differentiation—PTHLH—osteoporosis	0.00214	0.0288	CbGpPWpGaD
Prednicarbate—NR3C1—Glucocorticoid receptor regulatory network—NFATC1—osteoporosis	0.00214	0.0287	CbGpPWpGaD
Prednicarbate—NR3C1—Glucocorticoid receptor regulatory network—BGLAP—osteoporosis	0.00195	0.0261	CbGpPWpGaD
Prednicarbate—NR3C1—Nuclear Receptor transcription pathway—VDR—osteoporosis	0.00181	0.0243	CbGpPWpGaD
Prednicarbate—NR3C1—Nuclear Receptors—ESR1—osteoporosis	0.00175	0.0235	CbGpPWpGaD
Prednicarbate—NR3C1—Signaling events mediated by HDAC Class II—ESR1—osteoporosis	0.00175	0.0235	CbGpPWpGaD
Prednicarbate—NR3C1—Adipogenesis—WNT1—osteoporosis	0.00141	0.0189	CbGpPWpGaD
Prednicarbate—NR3C1—Nuclear Receptor transcription pathway—ESR1—osteoporosis	0.00138	0.0185	CbGpPWpGaD
Prednicarbate—NR3C1—SIDS Susceptibility Pathways—GAPDH—osteoporosis	0.00134	0.018	CbGpPWpGaD
Prednicarbate—NR3C1—Transcription factor regulation in adipogenesis—TNF—osteoporosis	0.00131	0.0176	CbGpPWpGaD
Prednicarbate—NR3C1—Adipogenesis—BMP2—osteoporosis	0.00128	0.0171	CbGpPWpGaD
Prednicarbate—NR3C1—Regulation of nuclear SMAD2/3 signaling—VDR—osteoporosis	0.00125	0.0168	CbGpPWpGaD
Prednicarbate—NR3C1—AP-1 transcription factor network—ESR1—osteoporosis	0.00107	0.0144	CbGpPWpGaD
Prednicarbate—NR3C1—Transcription factor regulation in adipogenesis—IL6—osteoporosis	0.00106	0.0142	CbGpPWpGaD
Prednicarbate—NR3C1—Regulation of nuclear SMAD2/3 signaling—ESR1—osteoporosis	0.000955	0.0128	CbGpPWpGaD
Prednicarbate—NR3C1—SIDS Susceptibility Pathways—ESR2—osteoporosis	0.000932	0.0125	CbGpPWpGaD
Prednicarbate—NR3C1—Glucocorticoid receptor regulatory network—POMC—osteoporosis	0.00085	0.0114	CbGpPWpGaD
Prednicarbate—NR3C1—Adipogenesis—IRS2—osteoporosis	0.0007	0.00939	CbGpPWpGaD
Prednicarbate—NR3C1—Adipogenesis—LEP—osteoporosis	0.000685	0.00919	CbGpPWpGaD
Prednicarbate—NR3C1—Adipogenesis—IRS1—osteoporosis	0.000611	0.0082	CbGpPWpGaD
Prednicarbate—NR3C1—Endoderm Differentiation—TGFB1—osteoporosis	0.00057	0.00764	CbGpPWpGaD
Prednicarbate—NR3C1—Adipogenesis—IGF1—osteoporosis	0.000566	0.00759	CbGpPWpGaD
Prednicarbate—NR3C1—AP-1 transcription factor network—MYC—osteoporosis	0.000558	0.00749	CbGpPWpGaD
Prednicarbate—NR3C1—AP-1 transcription factor network—TGFB1—osteoporosis	0.000557	0.00747	CbGpPWpGaD
Prednicarbate—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYC—osteoporosis	0.000496	0.00666	CbGpPWpGaD
Prednicarbate—NR3C1—SIDS Susceptibility Pathways—IL6R—osteoporosis	0.000496	0.00665	CbGpPWpGaD
Prednicarbate—NR3C1—Gene Expression—U2AF1—osteoporosis	0.000495	0.00664	CbGpPWpGaD
Prednicarbate—NR3C1—AP-1 transcription factor network—IL6—osteoporosis	0.000419	0.00563	CbGpPWpGaD
Prednicarbate—NR3C1—Generic Transcription Pathway—ESR2—osteoporosis	0.000394	0.00528	CbGpPWpGaD
Prednicarbate—NR3C1—SIDS Susceptibility Pathways—IL1B—osteoporosis	0.000377	0.00506	CbGpPWpGaD
Prednicarbate—NR3C1—Glucocorticoid receptor regulatory network—IL6—osteoporosis	0.00037	0.00496	CbGpPWpGaD
Prednicarbate—NR3C1—Gene Expression—RPL24—osteoporosis	0.000368	0.00493	CbGpPWpGaD
Prednicarbate—NR3C1—Adipogenesis—TGFB1—osteoporosis	0.000339	0.00455	CbGpPWpGaD
Prednicarbate—NR3C1—Adipogenesis—TNF—osteoporosis	0.000317	0.00425	CbGpPWpGaD
Prednicarbate—NR3C1—Generic Transcription Pathway—VDR—osteoporosis	0.000312	0.00419	CbGpPWpGaD
Prednicarbate—NR3C1—SIDS Susceptibility Pathways—TNF—osteoporosis	0.000274	0.00367	CbGpPWpGaD
Prednicarbate—NR3C1—Adipogenesis—IL6—osteoporosis	0.000256	0.00343	CbGpPWpGaD
Prednicarbate—NR3C1—Generic Transcription Pathway—ESR1—osteoporosis	0.000239	0.0032	CbGpPWpGaD
Prednicarbate—NR3C1—SIDS Susceptibility Pathways—IL6—osteoporosis	0.000221	0.00296	CbGpPWpGaD
Prednicarbate—NR3C1—Gene Expression—PSMA2—osteoporosis	0.000212	0.00285	CbGpPWpGaD
Prednicarbate—NR3C1—Gene Expression—PSMA5—osteoporosis	0.000212	0.00285	CbGpPWpGaD
Prednicarbate—NR3C1—Gene Expression—ESR2—osteoporosis	0.00019	0.00254	CbGpPWpGaD
Prednicarbate—NR3C1—Gene Expression—VDR—osteoporosis	0.00015	0.00202	CbGpPWpGaD
Prednicarbate—NR3C1—Generic Transcription Pathway—MYC—osteoporosis	0.000124	0.00167	CbGpPWpGaD
Prednicarbate—NR3C1—Gene Expression—ESR1—osteoporosis	0.000115	0.00154	CbGpPWpGaD
Prednicarbate—NR3C1—Gene Expression—MYC—osteoporosis	5.98e-05	0.000802	CbGpPWpGaD
